J N Gordon

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. ncbi Thalidomide and its derivatives: emerging from the wilderness
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton, Southampton General Hospital, Southampton
    Postgrad Med J 79:127-32. 2003
  2. ncbi Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
    J N Gordon
    Mailpoint 813, Level E, South Block, Southampton General Hospital, Southampton SO16 6YD, UK
    Gut 54:540-5. 2005
  3. ncbi Cancer cachexia
    J N Gordon
    Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, UK
    QJM 98:779-88. 2005
  4. ncbi Biological therapy in Crohn's disease
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD
    Hosp Med 64:708-12. 2003
  5. ncbi Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton School of Medicine, Southampton General Hospital, UK
    Gut 54:1213-5. 2005

Detail Information

Publications5

  1. ncbi Thalidomide and its derivatives: emerging from the wilderness
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton, Southampton General Hospital, Southampton
    Postgrad Med J 79:127-32. 2003
    ..This review summarises the biological effects, therapeutic applications, safety profile, and future potential of thalidomide and its derivatives...
  2. ncbi Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
    J N Gordon
    Mailpoint 813, Level E, South Block, Southampton General Hospital, Southampton SO16 6YD, UK
    Gut 54:540-5. 2005
    ..Thalidomide, which is an inhibitor of TNF-alpha synthesis, may represent a novel and rational approach to the treatment of cancer cachexia...
  3. ncbi Cancer cachexia
    J N Gordon
    Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, UK
    QJM 98:779-88. 2005
    ..We are now entering an exciting period in cachexia research, and it is likely that the next few years will see effective new biological therapies reach clinical practice...
  4. ncbi Biological therapy in Crohn's disease
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD
    Hosp Med 64:708-12. 2003
    ..Advances in understanding of the immunopathological basis of Crohn's disease are leading to the development of new biological therapies which are likely to play an increasing role in future...
  5. ncbi Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease
    J N Gordon
    Division of Infection, Inflammation, and Repair, University of Southampton School of Medicine, Southampton General Hospital, UK
    Gut 54:1213-5. 2005